Back
22nd Century Group Vs. Akero Therapeutics Industry Stock Comparison
Sell
31
XXII
22nd Century Group
Last Price:
0.24
Seasonality Move:
40.3%
Buy
59
AKRO
Akero Therapeutics
Last Price:
17.90
Seasonality Move:
2.55%
Sell
31
22nd Century Group (XXII)
is a Sell
Is 22nd Century Group a Buy, Sell or Hold?
- The current 22nd Century Group [XXII] share price is $0.24. The Score for XXII is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- XXII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $17.91. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XXII Stock Price Chart
What is 22nd Century Group's stock price today?
-
The 22nd Century Group share price today is $0.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XXII is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $17.91
The current trend is relatively stagnant and AKRO is experiencing slight selling pressure.
XXII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 32.04 | Sell |
| Chaikin Money Flow: | -1214060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.25 - 0.43) | Sell |
| Bollinger Bands (100): | (0.29 - 2.45) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 53.25 | Buy |
| Chaikin Money Flow: | -55617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.57 - 16.71) | Buy |
| Bollinger Bands (100): | (18.32 - 50.24) | Sell |
XXII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.73 | Buy |
| 20-day SMA: | 15.69 | Buy |
| 50-day SMA: | 21.8 | Sell |
| 200-day SMA: | 39.48 | Sell |
| 8-day EMA: | 16.85 | Buy |
| 20-day EMA: | 16.52 | Buy |
| 50-day EMA: | 21.96 | Sell |
| 200-day EMA: | 34.46 | Sell |
22nd Century Group Earnings Growth & XXII Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.79 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and an increase next year of $3.44 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
22nd Century Group Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||